Hospital Clínic de Barcelona

Hospital


Location: Barcelona, Spain (ES) ES

ISNI: 0000000096359413

ROR: https://ror.org/02a2kzf50

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Prognostic gene expression signature for high-grade serous ovarian cancer (2020) Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, et al. Journal article Determinants of Successful Use of Sirolimus in Renal Transplant Patients (2020) Naik MG, Jürgensen JS, Arns W, Basic E, Budde K, Eitner F, Fischereder M, et al. Journal article Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party (2020) Bazarbachi A, Labopin M, Angelucci E, Gülbas Z, Ozdogu H, Arat M, De Rosa L, et al. Journal article GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways (2019) López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, et al. Journal article Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution Impact of Eligibility Criteria on Clinical Outcomes of Firehawk and XIENCE Coronary Drug-Eluting Stent in an All-Comers Randomized Trial (2019) Saito Y, Wijns W, Baumbach A, Xu B, Kelbaek H, Van Royen N, Zheng M, et al. Conference contribution 2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent (2019) Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, et al. Journal article Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT acute leukemia working party (2019) Bazarbachi A, Labopin M, Angelucci E, Gulbas Z, Ozdogu H, Arat M, De Rosa L, et al. Conference contribution Chimeric antigen receptor T-cell therapy for multiple myeloma: A consensus statement from the European Myeloma Network (2019) Moreau P, Sonneveld P, Boccadoro M, Cook G, Victoria Mateos M, Nahi H, Goldschmidt H, et al. Journal article Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis (2019) Hannemann N, Cao S, Eriksson D, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, et al. Journal article
1 ... 4 5 6 7 8 9